Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Somatuline

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
CONTEXT Congenital hyperinsulinism (CH) may be treated conservatively in many children with octreotide given by multiple sc… Expand
Review
2001
Review
2001
Despite developments in diagnosis and treatment, lung cancer is the commonest cause of cancer death in Europe and North America… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
1995
1995
Background. Somatuline, a somatostatin analogue, as proven to be effective in several animal models of prostate cancer… Expand
1995
1995
Somatostatin analogues have been shown to suppress some hormones and growth factors involved in breast tumour growth and a direct… Expand
1994
1994
The aim of this work was to assess the use of a sustained-release formulation of somatuline, a long-acting analogue of… Expand
  • figure 1
  • figure 2
  • table I
Highly Cited
1994
Highly Cited
1994
This study was performed to evaluate whether the presence or absence of somatostatin receptors in malignant carcinoid tumours… Expand
  • table 1
Highly Cited
1993
Highly Cited
1993
To further investigate the antineoplastic efficacy and safety of somatostatin analogues, 2 trials were performed. Octreotide, SMS… Expand
Highly Cited
1993
Highly Cited
1993
Positron emission tomography (PET) makes it possible to study effects of medical treatment in vivo. Carcinoid tumors with liver… Expand
Highly Cited
1990
Highly Cited
1990
Four human small cell lung carcinomas, NCI-H69, NCI-N417, NCI-H345, LX-1, and a non-small cell lung carcinoma, H-165, implanted s… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
1990
1990
This study addresses, in an animal tumor model, the clinical problem of "escape from castration inhibition." Somatuline (BIM… Expand
  • figure I
  • table 1
  • table 2
  • figure 2
  • table 3